FDA to decide on SPN-830 apomorphine pump approval Feb. 1
The U.S. Food and Drug Administration (FDA) has set Feb. 1, 2025, as a goal date for deciding whether to…
Articles by Esteban Dominguez Cerezo
Potential apathy treatment IRL757 found safe in healthy volunteers
Irlab Therapeutics’ oral therapy IRL757 was safe and well tolerated in healthy volunteers in the first part of a Phase…
New site to manufacture stem cell therapy for Parkinson’s clinical trial
Aspen Neuroscience has opened a manufacturing facility for ANPD001, its investigational stem cell therapy for Parkinson’s disease being…
Technology using graphene, aiming for Parkinson’s, aids cancer surgery
A neural platform based on graphene, a strong but extremely thin carbon sheet that Inbrain Neuroelectronics is developing for…
Safety being seen in first 3 patients in stem cell therapy clinical trial
Reasonable safety is being seen in a first group of Parkinson’s disease patients who finished dosing in a Phase…
IU1 enhances protein clearance, may aid in treating Parkinson’s
A compound called IU1 may improve the body’s ability to maintain healthy proteins by boosting two critical processes that play…
Global data support RAB32 gene mutation’s link to Parkinson’s
A mutation in the RAB32 gene, which has been previously associated with Parkinson’s disease, was found in a significant…
Molecular ‘glue’ compound restores mutated parkin protein function
A small compound that acts as a molecular glue can activate a protein that’s often mutated in people with early-onset…
NIH supports work into brain-on-a-chip technology to study Parkinson’s
A National Institutes of Health (NIH) grant will fund the creation of a brain-on-a-chip technology, a microengineered device containing nerve…